Production (Stage)
Gain Therapeutics, Inc.
GANX
$1.73
-$0.07-3.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.67% | -13.81% | -28.85% | 33.77% | -24.62% |
| Total Receivables | 15.77% | 104.92% | 19.32% | 25.73% | 2.68% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 164.96% | -65.79% | 2.23% | 35.30% | 28.49% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -3.89% | -15.56% | -25.88% | 33.73% | -22.03% |
|
|
|||||
| Total Current Assets | -3.89% | -15.56% | -25.88% | 33.73% | -22.03% |
| Net Property, Plant & Equipment | -13.02% | -19.42% | -10.80% | -9.33% | -15.23% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -5.96% | -14.08% | -1.14% | -6.56% | -12.51% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.19% | -4.63% | 35.43% | 0.00% | -4.82% |
| Total Assets | -4.12% | -15.61% | -25.16% | 31.69% | -21.67% |
|
|
|||||
| Total Accounts Payable | 127.35% | -13.86% | -46.33% | 45.66% | 6.54% |
| Total Accrued Expenses | -1.81% | -1.90% | -27.74% | 49.01% | 8.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.43% | -8.75% | -0.27% | -5.55% | -9.50% |
| Total Finance Division Other Current Liabilities | -12.89% | -62.87% | -4.04% | -23.22% | -15.52% |
| Total Other Current Liabilities | -12.89% | -62.87% | -4.04% | -23.22% | -15.52% |
| Total Current Liabilities | 28.56% | -14.88% | -29.56% | 30.35% | 1.09% |
|
|
|||||
| Total Current Liabilities | 28.56% | -14.88% | -29.56% | 30.35% | 1.09% |
| Long-Term Debt | -4.20% | -12.71% | 0.19% | -5.39% | -11.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -42.91% | -44.28% | -28.37% | -24.30% | -22.84% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -4.11% | 26.21% | 2.72% | 6.17% | -11.29% |
| Total Liabilities | 22.16% | -12.32% | -26.38% | 24.87% | -1.59% |
|
|
|||||
| Common Stock & APIC | 3.20% | 3.12% | 1.63% | 15.38% | 0.41% |
| Retained Earnings | -5.58% | -4.87% | -6.15% | -12.57% | -6.60% |
| Treasury Stock & Other | 51.56% | -201.94% | 1,842.40% | -42.92% | -91.14% |
| Total Common Equity | -21.25% | -17.62% | -24.40% | 36.36% | -31.29% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.25% | -17.62% | -24.40% | 36.36% | -31.29% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.25% | -17.62% | -24.40% | 36.36% | -31.29% |
|
|
|||||